Identifying ways to increase the proportion of patients with melanoma who have clinically meaningful and durable responses to immune...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
As part of a growing public affairs program, the American Association for Cancer Research is excited to once again...
A big career fair can be somewhat intimidating, so we asked some hiring experts for their advice on how...
In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of...
The AACR has a robust program of educational workshops designed to equip early-career investigators with the knowledge, skills, and...
As social media continues to rapidly grow as a leading source of news and information, it has evolved to...
The AACR Annual Meeting, to be held in Washington, D.C., April 1-5, will showcase the best cancer science and...
Saturday, February 4, is World Cancer Day, an initiative of the Union for International Cancer Control (UICC).